about
Laulimalide induces dose-dependent modulation of microtubule behaviour in the C. elegans embryoSelective Tumor Targeting of Desacetyl Vinblastine Hydrazide and Tubulysin B via Conjugation to a Cholecystokinin 2 Receptor (CCK2R) LigandKilling cells by targeting mitosisClinicopathological relevance of kinesin family member 18A expression in invasive breast cancer.Proteomic identification of the oncoprotein STAT3 as a target of a novel Skp1 inhibitor.Mitosis as an anti-cancer drug target.BUB1 and BUBR1 inhibition decreases proliferation and colony formation, and enhances radiation sensitivity in pediatric glioblastoma cells.Up-regulation of pro-apoptotic protein Bim and down-regulation of anti-apoptotic protein Mcl-1 cooperatively mediate enhanced tumor cell death induced by the combination of ERK kinase (MEK) inhibitor and microtubule inhibitorRole of STAT3/5 and Bcl-2/xL in 2-methoxyestradiol-induced endoreduplication of nasopharyngeal carcinoma cells.OTX2 directly activates cell cycle genes and inhibits differentiation in medulloblastoma cells.Mitotic control of cancer stem cells.Defective cell cycle checkpoints as targets for anti-cancer therapies.Low cdc27 and high securin expression predict short survival for breast cancer patients.KIF18B promotes tumor progression through activating the Wnt/β-catenin pathway in cervical cancer.Occurrence of Aurora A positive multipolar mitoses in distinct molecular classes of colorectal carcinomas and effect of Aurora A inhibition.
P2860
Q27309120-ECDE8B3A-42BD-4F4F-9AF0-C3EC91F5B7D1Q35652998-4C8420D1-D0CF-4325-953B-7F3E49F2DE22Q35754713-5A98B48D-CA3A-4943-98CF-8071408FA460Q37204459-42623D74-03E5-44A0-90E6-BEABC8847428Q37709355-FEFC53A7-F311-4B18-BA6C-4B339C97080CQ38115166-5CC8AD5C-4AAF-49DD-9D8E-4C026AC89D3CQ39144762-8944A0FE-42AF-469A-89AC-5CCC5362919DQ39407551-59BEB2F8-D2FF-4A59-9812-75B084FB8777Q39456688-29A81D68-5A8E-468B-A0ED-08C2DC3C9805Q39464542-735CA0DB-EFDC-401A-972F-35FBE6471A66Q39583292-E1B513B8-151D-4326-B7E6-E5FC9D698FD3Q40794273-FFD2E317-264D-4720-A1D0-A77D116012AEQ50918197-6F498DAD-C6A5-4FD9-8969-F405E24C3091Q52595286-980AC765-5CA6-4459-BCB2-F5C69FF0AF75Q54360576-B43E1463-A078-4E7E-83F4-85F157FEACE7
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on October 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Mitotic drug targets.
@en
Mitotic drug targets.
@nl
type
label
Mitotic drug targets.
@en
Mitotic drug targets.
@nl
prefLabel
Mitotic drug targets.
@en
Mitotic drug targets.
@nl
P356
P1476
Mitotic drug targets.
@en
P2093
Holger Bastians
Phillip Kaestner
P304
P356
10.1002/JCB.22721
P577
2010-10-01T00:00:00Z